FORM 10-Q
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
(Mark One)
ý
QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2003
OR
o
TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission File No. 1-9328
ECOLAB INC.
(Exact name of registrant as specified in its charter)
Delaware
41-0231510
(State or other jurisdiction ofincorporation or organization)
(I.R.S. EmployerIdentification No.)
370 Wabasha Street N., St. Paul, Minnesota 55102
(Address of principal executive offices) (Zip Code)
651-293-2233
(Registrants telephone number, including area code)
(Not Applicable)
(Former name, former address and former fiscal year,if changed since last report)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes ý No o
Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).
Indicate the number of shares outstanding of each of the issuers classes of common stock, as of October 31, 2003.
257,651,933 shares of common stock, par value $1.00 per share.
Table of Contents
PART I
FINANCIAL INFORMATION
Item 1. Financial Statements.
Consolidated Statement of Income
Consolidated Balance Sheet
Consolidated Statement of Cash Flows
Notes to Consolidated Financial Statements
1.
Consolidated Financial Information
2.
Stock-Based Compensation
3.
Selected Balance Sheet Information
4.
Financial Instruments
5.
Comprehensive Income
6.
Special Charges
7.
Gain from Discontinued Operations
8.
Business Acquisitions and Investments
9.
Income Per Common Share
10.
Operating Segments
11.
Goodwill and Other Intangible Assets
12.
New Accounting Pronouncements
Report of Independent Auditors
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations.
Results of Operations
Financial Position and Liquidity
Issuer Purchases of Equity Securities
Subsequent Event
Item 3. Quantitative and Qualitative Disclosures About Market Risk.
Item 4. Controls and Procedures.
Forward-Looking Statements and Risk Factors
PART II
OTHER INFORMATION
Item 6. Exhibits and Reports on Form 8-K.
PART I - FINANCIAL INFORMATION
CONSOLIDATED STATEMENT OF INCOME
Third Quarter EndedSeptember 30
(amounts in thousands, except per share)
2003
2002
(unaudited)
Net sales
$
982,766
894,866
Cost of sales (including special charges of $301 in 2002)
478,163
434,195
Selling, general and administrative expenses
357,923
327,666
Special charges
1,224
2,109
Operating income
145,456
130,896
Gain on sale of equity investment
10,877
Interest expense, net
12,051
10,988
Income before income taxes
144,282
119,908
Provision for income taxes
56,843
47,826
Net income
87,439
72,082
Basic net income per common share
0.34
0.28
Diluted net income per common share
0.33
Dividends declared per common share
0.0725
0.0675
Weighted-average common shares outstanding
Basic
258,694
258,575
Diluted
261,609
261,223
The accompanying notes are an integral part of the consolidated financial information.
2
Nine Months EndedSeptember 30
2,805,353
2,520,205
Cost of sales (including special charges (income) of $(45) in 2003 and $7,393 in 2002)
1,375,379
1,243,565
1,060,739
947,974
880
26,223
368,355
302,443
34,506
33,455
Income from continuing operations before income taxes
344,726
268,988
134,814
108,204
Income from continuing operations before cumulative effect of change in accounting
209,912
160,784
Change in accounting for goodwill and other intangible assets
(4,002
)
Gain from discontinued operations
1,882
158,664
Basic income per common share
Income from continuing operations
0.81
0.62
Change in accounting
(0.02
0.01
Diluted income per common share
0.80
0.61
0.2175
0.2025
260,129
257,732
263,378
261,126
Per share amounts do not necessarily sum due to rounding.
3
CONSOLIDATED BALANCE SHEET
(amounts in thousands)
September 302003
December 312002
ASSETS
Current assets
Cash and cash equivalents
66,962
49,205
Accounts receivable, net
649,841
553,154
Inventories
313,668
291,506
Deferred income taxes
73,925
71,147
Other current assets
51,492
50,925
Total current assets
1,155,888
1,015,937
Property, plant and equipment, net
693,355
680,265
Goodwill, net
744,217
695,700
Other intangible assets, net
198,617
188,670
Other assets, net
272,770
285,335
Total assets
3,064,847
2,865,907
(Continued)
4
CONSOLIDATED BALANCE SHEET (Continued)
LIABILITIES AND SHAREHOLDERS EQUITY
Current liabilities
Short-term debt
75,375
160,099
Accounts payable
209,528
205,665
Compensation and benefits
168,951
184,239
Income taxes
90,710
12,632
Other current liabilities
324,837
291,193
Total current liabilities
869,401
853,828
Long-term debt
573,963
539,743
Postretirement health care and pension benefits
219,875
207,596
Other liabilities
169,764
164,989
Shareholders equity(common stock, par value $1.00 per share; shares outstanding: September 30, 2003 258,050; December 31, 2002 129,940)
1,231,844
1,099,751
Total liabilities and shareholders equity
5
CONSOLIDATED STATEMENT OF CASH FLOWS
OPERATING ACTIVITIES
Cumulative effect of change in accounting
4,002
(1,882
Adjustments to reconcile income from continuing operations to cash provided by operating activities:
Depreciation
152,116
139,664
Amortization
21,391
20,919
2,054
(3,203
(10,877
Special charges - asset disposals
1,665
4,810
Other, net
1,063
630
Changes in operating assets and liabilities:
Accounts receivable
(59,315
(30,531
(8,681
(5,325
Other assets
18,020
(31,331
(5,922
(5,900
77,456
117,443
Cash provided by operating activities
398,882
367,960
6
CONSOLIDATED STATEMENT OF CASH FLOWS (Continued)
INVESTING ACTIVITIES
Capital expenditures
(148,649
(145,459
Property disposals
5,731
5,858
Capitalized software expenditures
(5,912
(2,150
Businesses acquired and investments in affiliates
(28,881
(21,606
Sale of businesses and assets
24,832
Cash used for investing activities
(152,879
(163,357
FINANCING ACTIVITIES
Net repayments of notes payable
(83,246
(370,796
Long-term debt borrowings
16
257,624
Long-term debt repayments
(10,065
(917
Reacquired shares
(198,947
(9,004
Cash dividends on common stock
(56,643
(52,108
Exercise of employee stock options
119,525
24,401
(129
(1,404
Cash used for financing activities
(229,489
(152,204
Effect of exchange rate changes on cash
1,243
1,270
INCREASE IN CASH AND CASH EQUIVALENTS
17,757
53,669
Cash and cash equivalents, beginning of period
41,793
Cash and cash equivalents, end of period
95,462
7
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
1. Consolidated Financial Information
The unaudited consolidated financial information as of September 30, 2003 and for the three and nine-month periods ended September 30, 2003 and 2002, reflect, in the opinion of management, all adjustments necessary for a fair presentation of the financial position, results of operations and cash flows of Ecolab Inc. (the company) for the interim periods presented. The financial results for any interim period are not necessarily indicative of results for the full year. The consolidated balance sheet data as of December 31, 2002 were derived from the audited consolidated financial statements, but do not include all disclosures required by accounting principles generally accepted in the United States of America. The unaudited consolidated financial information should be read in conjunction with the consolidated financial statements and notes thereto incorporated in the companys Annual Report on Form 10-K for the year ended December 31, 2002.
With respect to the unaudited financial information of the company as of September 30, 2003 and for the three and nine-month periods ended September 30, 2003 and 2002, included in this Form 10-Q, PricewaterhouseCoopers LLP reported that they have applied limited procedures in accordance with professional standards, which do not require an audit, for a review of such information. Therefore, their separate report dated October 21, 2003 appearing herein, states that they did not audit and they do not express an opinion on that unaudited financial information. Accordingly, the degree of reliance on their report on such information should be restricted in light of the limited nature of the review procedures applied. PricewaterhouseCoopers LLP is not subject to the liability provisions of Section 11 of the Securities Act of 1933 (the Act) for their report on the unaudited financial information because that report is not a report or a part of a registration statement prepared or certified by PricewaterhouseCoopers LLP within the meaning of Sections 7 and 11 of the Act.
The Consolidated Balance Sheet as of December 31, 2002 includes a reclassification of $12,522,000 of accumulated amortization to a long lived asset that was previously classified as an other current liability to be consistent with the current period presentation.
On June 6, 2003, the company paid a two-for-one common stock split in the form of a 100 percent stock dividend to shareholders of record on May 23, 2003 which resulted in a transfer of $154,737,694 from additional paid in capital to common stock. Weighted average shares outstanding and earnings per share data for all periods presented have been adjusted to reflect the stock split.
2. Stock-Based Compensation
The company measures compensation cost for its stock incentive and option plans using the intrinsic value-based method of accounting.
Had the company used the fair value-based method of accounting to measure compensation expense for its stock incentive and option plans and charged compensation cost against income over the vesting periods, based on the fair value of options at the date of grant, net income and the related basic and diluted per common share amounts for the three and nine-month periods ended September 30, 2003 and 2002 would have been reduced to the pro forma amounts in the following table.
8
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
2. Stock-Based Compensation (continued)
Earnings per share data for all periods presented have been adjusted to reflect the stock split described in Note 1.
(unaudited )
Net income, as reported
Add: Stock-based employee compensation expense included in reported net income, net of tax
171
383
884
1,396
Deduct: Total stock-based employee compensation expense under fair value-based method, net of tax
(4,395
(3,747
(13,628
(11,488
Pro forma net income
83,215
68,718
197,168
148,572
As reported
Pro forma
0.32
0.27
0.76
0.58
0.26
0.75
0.57
3. Selected Balance Sheet Information
Finished goods
151,702
136,721
Raw materials and parts
164,491
156,628
Excess of fifo cost over lifo cost
(2,525
(1,843
Total
Customer relationships
143,102
120,324
Intellectual property
72,456
71,104
Trademarks
52,342
50,308
Other intangibles
16,399
13,502
284,299
255,238
Accumulated amortization
(85,682
(66,568
9
3. Selected Balance Sheet Information (continued)
Shareholders equity
Common stock
309,860
151,950
Additional paid-in capital
360,460
386,208
Retained earnings
1,313,041
1,159,663
Deferred compensation, net
(505
(1,710
Accumulated other comprehensive loss
(31,773
(76,108
Treasury stock
(719,239
(520,252
Accumulated other comprehensive loss as of September 30, 2003 consists of $2,373,000 of net unrealized losses primarily on financial instruments and $29,400,000 of cumulative translation losses. Accumulated other comprehensive loss as of December 31, 2002 consists of $1,571,000 of net unrealized losses primarily on financial instruments and $74,537,000 of cumulative translation losses.
4. Financial Instruments
In February 2002, the company issued euro 300 million of 5.375 percent Euronotes, due February 2007. The company designated a portion (approximately euro 250 million as of the end of the third quarter 2003) of this Euronote debt as a hedge of existing foreign currency exposures related to net investments the company has in certain European subsidiaries. Accordingly, the transaction gains and losses on the portion of the Euronotes that are designated and are effective as hedges of the companys net investments have been included as a component of the cumulative translation account. Total transaction gains and losses related to the Euronotes charged to shareholders equity were approximately $24.2 million of transaction gains and $22.3 million of transaction losses for the third quarter and first nine months of 2003, respectively.
In June 2003, the company established a $200 million European commercial paper program to provide a source of funding for European and other international acquisitions and working capital requirements. The program is in addition to the companys $450 million U.S. and $200 million Australian dollar programs. All three programs are rated A-1 by Standard & Poors and P-1 by Moodys and are supported by the companys $275 million multi-year committed credit facility (terminating December 2005) and $175 million 364-day committed credit facility (terminating October 2003). Subsequent to September 30, 2003, the $175 million 364-day committed credit facility was renewed through October 2004.
10
5. Comprehensive Income
Comprehensive income was as follows:
Foreign currency translation
(27,146
18,581
45,137
18,729
Derivative instruments
980
2,110
(802
3,782
Comprehensive income
61,273
92,773
254,247
181,175
6. Special Charges
In the first quarter of 2002, management approved plans to undertake restructuring and cost saving actions during 2002, including costs related to the integration of the companys European operations. These actions included global workforce reductions, facility closings, and product line discontinuations. A portion of these actions was completed during the three- and nine-month periods ended September, 30, 2002 and, as a result, the company recorded restructuring expense of $1,438,000 ($896,000 after tax), for the third quarter of 2002 and restructuring expense of $36,554,000 ($22,774,000 after tax), for the first nine months of 2002. This includes $1,004,000 for employee termination benefits, $187,000 for asset disposals and $247,000 for other charges in the third quarter of 2002. For the nine months ended September 30, 2002, this includes $28,584,000 for employee termination benefits, $4,810,000 for asset disposals and $3,160,000 for other charges. The company also incurred merger integration costs of $972,000 ($536,000 after tax) and $2,853,000 ($1,808,000 after tax) in the third quarter and the first nine months of 2002, respectively, related to European and other operations. Restructuring and merger integration costs have been included as special charges on the consolidated statement of income with a portion of restructuring expenses included as a component of cost of sales. Amounts included as a component of cost of sales include asset disposals of $187,000 and manufacturing related severance of $114,000 for the third quarter of 2002. For the first nine months of 2002 amounts included in cost of sales include asset disposals of $4,810,000 and manufacturing related severance of $2,583,000.
Also included in special charges on the consolidated statement of income for the first nine months of 2002 is a one-time curtailment gain of $5,791,000 ($3,501,000 after tax) related to changes to postretirement healthcare benefits made in the first quarter of 2002.
Restructuring liabilities are classified as a component of other current liabilities.
11
6. Special Charges (continued)
Employee termination benefit expenses in the third quarter of 2002 included 56 personnel reductions through voluntary and involuntary terminations. Total personnel reductions during the first nine months of 2002 were 542 people, with the possibility that some of these people may be replaced. Individuals were affected through facility closures and consolidation primarily within the corporate administrative, operations and research and development functions.
Asset disposals include inventory and property, plant, and equipment charges. Net inventory and property, plant and equipment charges for the third quarter were $187,000 and include the reversal of $202,000 previously expensed in the first quarter of 2002. During the first nine months of 2002, inventory charges were $2,223,000, and reflect the discontinuance of product lines which are not consistent with the companys long-term strategies. Property, plant and equipment charges during the third quarter and first nine months of 2002 were $2,587,000, and reflect the downsizing and closure of production facilities as well as global changes to manufacturing and distribution operations in connection with the integration of European operations.
Other charges include lease termination costs and other miscellaneous exit costs.
The company continued to record restructuring and merger integration charges throughout 2002 and completed these activities by December 31, 2002.
The three- and nine-month periods ended September 30, 2003 include the reversal of $448,000 and $837,000, respectively, of previously accrued severance cost. Of the $837,000 reversed for the nine-month period ended September 30, 2003, $45,000 is included as a component of cost of sales.
Also included in Special Charges on the consolidated statement of income for the three- and nine-month periods ended September 30, 2003 is $1,672,000 of expense related to a change in the amount of goodwill allocated to the Darenas business which was sold earlier in the year.
For segment reporting purposes, each of these items in both 2002 and 2003 have been included in the companys corporate segment, which is consistent with the companys internal management reporting.
12
Changes to the restructuring liability accounts during 2003 include the following:
(thousands)
EmployeeTerminationBenefits
AssetDisposals
Other
Expense and accrual in 2002
36,366
6,180
5,221
47,767
Cash payments in 2002
(16,033
(1,711
(17,744
Non-cash charges in 2002
(6,180
Restructuring liability, December 31,2002
20,333
3,510
23,843
Cash payments
(8,358
(713
(9,071
Revisions to prior estimates
(235
(7
(242
Non-cash charges
Effect of exchange rate changes
617
569
1,186
Restructuring liability, March 31, 2003
12,357
3,366
15,723
(4,343
(475
(4,818
(147
267
48
315
Restructuring liability June 30, 2003
8,134
2,939
11,073
(2,427
(944
(3,371
(448
199
32
231
Restructuring liability September 30, 2003
5,458
2,027
7,485
13
7. Gain From Discontinued Operations
During the first quarter of 2002, the company resolved a legal issue related to the disposal of its Chemlawn business in 1992. This resulted in the recognition of a gain from discontinued operations of $1,882,000 (net of income tax benefit of $1,079,000) or $0.01 per diluted share for the nine months ended September 30, 2002.
8. Business Acquisitions and Investments
In December 2002 (subsequent to the companys International operations year-end), the company acquired the Adams Healthcare business of Medical Solutions plc. Adams Healthcare is a leading supplier of hospital hygiene products in the United Kingdom with annual sales of approximately $19 million. These operations have become part of the companys International Cleaning & Sanitizing segment.
This acquisition has been accounted for as a purchase and, accordingly, the results of its operations have been included in the financial statements of the company from the date of acquisition. Net sales and operating income of this business are not significant to the companys consolidated results of operations, financial position and cash flows.
The total cash paid by the company for acquisitions and investments in affiliates during the first nine months of 2003 was $28,881,000. This included payments in 2003 of accrued costs related to the Henkel-Ecolab acquisition at year-end 2001 and other acquisition costs that were accrued related to businesses acquired in 2002.
Also in December 2002, the company sold its Darenas janitorial products distribution business based in Birmingham, UK to Bunzl plc in London, UK. This sale resulted in a loss of approximately $1.7 million principally due to the amount of goodwill allocated to the Darenas business. The annualized sales of this entity were approximately $30 million. These operations were part of the companys International Cleaning & Sanitizing segment.
In June 2003 the company sold its minority equity investment in Comac S.p.A., a floor care machine manufacturing company based in Verona, Italy to an investment group for a gain of approximately $10.9 million ($6.2 million after tax). These operations were part of the companys International Cleaning & Sanitizing segment.
In September 2003 (subsequent to the companys International operations quarter end), the company sold the consumer dermatology business of its Adams Healthcare subsidiary to Ferndale Pharmaceuticals Ltd., in Leeds, United Kingdom at a nominal gain. The annualized sales of the dermatology business that was sold were approximately $2.5 million. These operations were a part of the companys International Cleaning & Sanitizing segment.
14
8. Business Acquisitions and Investments (continued)
The changes in the carrying amount of goodwill for each of the companys reportable segments for the quarter and nine months ended September 30, 2003 were as follows:
United States
Cleaning &Sanitizing
OtherServices
InternationalCleaning &Sanitizing
Consolidated
Balance as of December 31, 2002
121,979
49,306
171,285
524,415
Goodwill acquired during quarter
73
(377
(304
381
77
38,894
Balance as of March 31, 2003
122,052
48,929
170,981
563,690
734,671
119
(228
(109
45,746
Balance as of June 30, 2003
122,171
171,100
609,208
780,308
33
0
Goodwill allocated to business dispositions
(1,672
(34,452
Balance as of September 30, 2003
122,204
171,133
573,084
Goodwill acquired in 2003 also includes adjustments to prior year acquisitions. International Cleaning & Sanitizing goodwill acquired in 2003 includes goodwill acquired of $5.9 million in the first quarter primarily related to the Adams Healthcare acquisition and a reduction of $5.6 million in the first quarter and $0.2 million in the second quarter for an adjustment related to the Terminix acquisition in 2002. These adjustments primarily related to a finalization of the pension valuation at the date of acquisition. United States Other Services goodwill acquired in the first quarter of 2003 includes a reduction of $0.4 million for an adjustment related to the Audits International acquisition. Goodwill disposed during the third quarter related to a change in the amount of goodwill allocated to the Darenas business which was sold earlier in the year.
15
9. Income Per Common Share
The computations of the basic and diluted income from continuing operations per share amounts were as follows:
Effect of dilutive stock options and awards
2,915
2,648
3,249
3,394
Income from continuing operations before change in accounting per common share
Share and per share data for all periods presented above have been adjusted to reflect the stock split described in Note 1.
Restricted stock awards of approximately 111,000 and 171,000 shares were excluded from the companys calculation of basic income per share amounts for the third quarter and nine months ended September 30, 2003, respectively, and 256,000 and 343,000 shares were excluded for the third quarter and nine months ended September 30, 2002, respectively, because such shares were not yet vested at those dates.
Stock options to purchase approximately 0.2 million shares for both the third quarter and nine months ended September 30, 2003 and stock options to purchase approximately 4.4 million shares for both the third quarter and nine months ended September 30, 2002 were not dilutive and, therefore, were not included in the computations of diluted common shares outstanding.
10. Operating Segments
Financial information for each of the companys reportable segments is as follows:
Net Sales
Cleaning & Sanitizing
444,791
426,339
1,292,991
1,220,801
Other Services
83,497
81,629
239,789
230,943
528,288
507,968
1,532,780
1,451,744
International Cleaning & Sanitizing
399,967
380,328
1,150,121
1,094,412
Effect of foreign currency translation
54,511
6,570
122,452
(25,951
Operating Income
82,472
80,361
224,321
214,280
8,755
10,761
19,187
25,247
91,227
91,122
243,508
239,527
48,694
41,711
112,558
98,473
Corporate expense
(1,184
(2,411
(836
(33,617
6,719
474
13,125
(1,940
The International Cleaning & Sanitizing amounts included above are based on translation into U.S. dollars at the fixed currency exchange rates used by management for 2003.
Consistent with the companys internal management reporting, corporate operating expense for the third quarter and for the nine months ended September 30, 2003 includes approximately $1.7 million of expense related to a change in the amount of goodwill allocated to the Darenas business. It also includes $0.5 million and $0.8 million of reductions in restructuring expense for the third quarter and nine months ended September 30, 2003, respectively.
Corporate expense in the third quarter and first nine months of 2002 includes restructuring and integration charges of approximately $2.4 million and $39.4 million, respectively. Corporate expense for the first nine months of 2002 also includes a curtailment gain of approximately $5.8 million due to benefit plan changes. These items are described more fully in Note 6.
17
11. Goodwilland Other Intangible Assets
Effective January 1, 2002, the company adopted the provisions of Statement of Financial Accounting Standards (SFAS) No. 142, Goodwill and Other Intangible Assets. This statement discontinued the amortization of goodwill and indefinite-lived intangible assets, subject to periodic impairment testing. The company was required to test all existing goodwill for impairment as of January 1, 2002 on a reporting unit basis. The companys reporting units are its operating segments. Under SFAS No. 142, the fair value approach was used to test goodwill for impairment. This method differs from the companys prior policy of using an undiscounted cash flows method for testing goodwill impairment. An impairment charge is recognized for the amount, if any, by which the carrying amount of goodwill exceeds its implied fair value. Fair values of reporting units were established using a discounted cash flow method. Where available and as appropriate, comparative market multiples were used to corroborate the results of the discounted cash flow method.
The result of testing goodwill for impairment in accordance with SFAS No. 142 as of January 1, 2002, was a non-cash charge of $4.0 million ($0.02 per share), which is reported on the accompanying consolidated statement of income in the caption Change in accounting for goodwill and other intangible assets. All of the impairment charge related to the Africa/Export reporting unit, which is part of the International Cleaning and Sanitizing segment. The primary factor resulting in the impairment charge was the difficult economic environment in the region. No impairment charge was appropriate under the companys previous goodwill impairment policy, which was based on an undiscounted cash flow model.
Under SFAS No. 142, goodwill must be tested annually for impairment. As of September 30, 2003, the company has completed its annual test for goodwill impairment. Based on this testing, there is no additional impairment of goodwill.
Goodwill and other intangible assets arise principally from business acquisitions. Goodwill represents the excess of the purchase price over the fair value of net assets acquired. Other intangible assets include primarily customer relationships, trademarks, patents and other technology. Other intangible assets are amortized on a straight-line basis over their estimated economic lives that results in a weighted average useful life of 12 years as of September 30, 2003.
The straight-line method of amortization reflects an appropriate allocation of the cost of the intangible assets to earnings in proportion to the amount of economic benefits obtained by the company in each reporting period. Total amortization expense related to other intangible assets during the third quarter ended September 30, 2003 and 2002 was approximately $6.5 million and $5.3 million, respectively. Total amortization expense related to other intangible assets during the nine months ended September 30, 2003 and 2002 was approximately $15.9 million and $13.8 million, respectively. As of September 30, 2003, future estimated amortization expense related to amortizable other identifiable intangible assets will be (amounts in thousands):
18
11. Goodwill and Other Intangible Assets (continued)
Fiscal Year (thousands)
Remainder 2003 (three month period)
5,067
2004
19,974
2005
18,578
2006
18,263
2007
17,737
2008
16,393
12. New Accounting Pronouncements
In January 2003, the Financial Accounting Standards Board (FASB) issued FASB Interpretation No. 46, Consolidation of Variable Interest Entities(FIN 46). FIN 46 provides accounting requirements for business enterprises to consolidate related entities in which they are determined to be the primary beneficiary as a result of their variable economic interests. The interpretation provides guidance in judging multiple economic interests in an entity and in determining the primary beneficiary. The interpretation outlines consolidation and disclosure requirements for variable interest entities (VIEs). On October 8, 2003, the FASB decided to defer the implementation date for FIN 46 for VIEs existing prior to January 31, 2003 to the first reporting period ending after December 15, 2003. The company has reviewed the consolidation and disclosure requirements of FIN 46 and determined that it has no current impact on the company.
In April 2003, the FASB issued Statement of Financial Accounting Standards (SFAS) No. 149, Amendment of Statement 133 on Derivative Instruments and Hedging Activities. This statement amends and clarifies financial accounting and reporting for derivative instruments, including certain derivative instruments embedded in other contracts and for hedging activities under SFAS No. 133, Accounting for Derivative Instruments and Hedging Activities. The company has reviewed the requirements of this standard and it has no impact on the company.
In May 2003, the FASB issued SFAS No. 150, Accounting for Certain Financial Instruments with Characteristics of both Liabilities and Equity. This statement establishes standards for how an issuer classifies and measures certain financial instruments with characteristics of both liabilities and equity. SFAS No. 150 is effective for financial instruments entered into or modified after May 31, 2003, and otherwise is effective at the beginning of the first interim period after June 15, 2003. The company does not have any financial instruments subject to SFAS No. 150 as of September 30, 2003.
19
REPORT OF INDEPENDENT AUDITORS
To the Shareholders and Directors
Ecolab Inc.
We have reviewed the accompanying consolidated balance sheet of Ecolab Inc. as of September 30, 2003, and the related consolidated statements of income for each of the three and nine-month periods ended September 30, 2003 and 2002, and of cash flows for the nine-month periods ended September 30, 2003 and 2002. These financial statements are the responsibility of the Companys management.
We conducted our reviews in accordance with standards established by the American Institute of Certified Public Accountants. A review of interim financial information consists principally of applying analytical procedures to financial data and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with auditing standards generally accepted in the United States of America, the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion.
Based on our reviews, we are not aware of any material modifications that should be made to the accompanying consolidated interim financial statements referred to above for them to be in conformity with accounting principles generally accepted in the United States of America.
We have previously audited, in accordance with auditing standards generally accepted in the United States of America, the consolidated balance sheet as of December 31, 2002, and the related consolidated statements of income, of comprehensive income and shareholders equity, and of cash flows for the year then ended (not presented herein); and in our report dated February 18, 2003, we expressed an unqualified opinion on those consolidated financial statements. In our opinion, the information set forth in the accompanying consolidated balance sheet as of December 31, 2002, is fairly stated, in all material respects, in relation to the consolidated balance sheet from which it has been derived.
/s/ PricewaterhouseCoopers LLP
PRICEWATERHOUSECOOPERS LLP
Minneapolis, Minnesota
October 21, 2003
20
MANAGEMENTS DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The following discussion and analysis provides information that management believes is useful in understanding the companys operating results, cash flows and financial condition. The discussion should be read in conjunction with the consolidated financial statements and related notes included in this Form 10-Q.
The following discussion contains various Forward-Looking Statements within the meaning of the Private Securities Litigation Reform Act of 1995. We refer readers to the companys statement entitled Forward-Looking Statements and Risk Factors located at the end of Part I of this report. Additional risk factors may be described from time to time in Ecolabs filings with the Securities and Exchange Commission.
Results of Operations - Third Quarter and Nine Months Ended September 30, 2003
On June 6, 2003, the company paid a two-for-one common stock split in the form of a 100 percent stock dividend to shareholders of record on May 23, 2003. Weighted average shares outstanding and earnings per share data for all periods presented have been adjusted to reflect the stock split.
The comparability of the companys results of operations between the first nine months of 2003 and 2002 have been impacted by the change in accounting for goodwill and other intangible assets from the adoption of SFAS No. 142 and a gain from discontinued operations as shown in the table below.
(Diluted earnings per share)
Income from continuing operations before change in accounting
In addition, the comparison of the financial results for the third quarter and the first nine months of 2003 were also affected by a gain on the sale of an equity investment of $6.2 million after tax and special charges. The special charges include approximately $1.7 million of expense related to a change in the amount of goodwill allocated to the Darenas business, and $0.3 million and $0.5 million of reductions in restructuring expense after tax for the third quarter and nine months ended September 30, 2003, respectively. During the third quarter and first nine months of 2002, special charges related to restructuring activities and the integration of the European operations were incurred of $1.4 million after tax and $24.6 million after tax, respectively. In 2002, the first nine months include a one-time gain from benefit plan changes of $3.5 million after tax.
21
Results of Operations - Third Quarter and Nine Months Ended September 30, 2003 (continued)
Consolidated net sales for the third quarter ended September 30, 2003 were $983 million, an increase of 10 percent over net sales of $895 million in the third quarter of last year. For the first nine months of 2003, net sales increased 11 percent to $2.805 billion from $2.520 billion in the comparable period of 2002. Excluding acquisitions and divestitures, consolidated net sales increased 9 percent in the third quarter and 10 percent for the first nine months of 2003. Changes in currency translation positively impacted sales growth by approximately 5 percentage points for the third quarter and approximately 6 percentage points for the nine months ended September 30, 2003. Sales also benefited from aggressive new account sales, successful new products and improved service initiatives.
The gross profit margin was 51.3 percent and 51.5 percent of net sales for the third quarter ended September 30, 2003 and 2002, respectively. For the nine-month periods, the gross profit margins were 51.0 percent in 2003 and 50.7 percent in 2002. The gross profit margin reflected certain restructuring charges included in cost of sales of $0.3 million and $7.4 million for the third quarter and first nine months of 2002, respectively. Excluding these restructuring charges, the gross profit margin would have been 51.5 percent for the third quarter and 50.9 percent for the nine months ended September 30, 2002, respectively. The decrease in the gross margin for the third quarter compared with the adjusted 2002 gross margin is due to business mix and raw material price increases. The year-to-date margin benefited from increased sales volume and cost reduction actions, partially offset by business mix and raw material price increases.
Selling, general and administrative expenses were 36.4 percent of consolidated net sales for the third quarter of 2003, a decrease from 36.6 percent of net sales in the comparable quarter of last year. This decrease is largely due to cost saving initiatives and business mix being partially offset by service investments and higher payroll costs. For the nine-month period, selling, general and administrative expenses increased as a percentage of net sales to 37.8 percent in 2003 from 37.6 percent in 2002. This increase in the margin is primarily due to an increase in sales and service investments and higher payroll and health care costs partially offset by increased sales volume and cost savings initiatives.
In the first quarter of 2002, management approved plans to undertake restructuring and cost-saving actions during 2002, including costs related to the integration of the companys European operations. These actions included global workforce reductions, facility closings, and product line discontinuations. As a result, the company recorded restructuring expenses and other special charges of $2.4 million in the third quarter of 2002 ($1.4 million after tax) and $39.4 million for the nine months ended September 30, 2002 ($24.6 million after tax). Offsetting these special charges for the nine months ended September 30, 2002, is a one-time curtailment gain of $5.8 million ($3.5 million after tax), related to changes to post-retirement healthcare benefits made in the first quarter of 2002. The expected cost savings related to restructuring activities started in 2002 and are expected to have a full impact in 2003. For the third quarter of 2003 and 2002,
22
restructuring savings were approximately $7.4 million and $5.2 million, respectively. For the nine months ended September 30, 2003 and 2002, restructuring savings were approximately $23.1 million and $10.5 million, respectively. Some of these savings were reinvested in the business. The company expects annual pretax savings of $25 million to $30 million ($15 million to $18 million after tax) and the company expects to continue to reinvest some of these savings in the business.
Net income totaled $87 million, for the third quarter of 2003 and $72 million for the comparable period of 2002. On a per share basis, diluted net income per common share was $0.33 for the third quarter of 2003 and increased 18 percent over diluted net income per share of $0.28 in the third quarter of last year. For the first nine months of 2003, net income was $210 million as compared to net income of $159 million in the comparable period of last year. Diluted net income per share increased 31 percent to $0.80 for the nine months ended September 30, 2003 from $0.61 for the first nine months of last year. The increase in third quarter and year-to-date earnings includes several one-time items. The financial results for the third quarter and the first nine months of 2003 included a gain on the sale of an equity investment of $6.2 million after tax and special charges. Special charges include approximately $1.7 million of expense related to a change in the amount of goodwill allocated to a business for the quarter and nine months ended September 30, 2003. Special charges also include $0.3 million and $0.5 million of reductions in previously recorded restructuring expenses (after tax) for the third quarter and nine months ended September 30, 2003, respectively. Currency translation positively impacted net income by approximately $4 million for the third quarter of 2003 and benefited net income by approximately $9 million for the first nine months of 2003. The comparison of net income also benefited from a lower effective tax rate in 2003.
Sales for each of the companys reportable segments for the quarter and nine months ended September 30, 2003 and 2002 are as follows:
23
The following table shows the increase in sales by division for the third quarter and nine months ended September 30, 2003:
Percent ChangeThird Quarter
Percent ChangeNine Months
United States Cleaning & Sanitizing
Institutional
%
Kay
Textile Care
(11
(9
Professional Products
Water Care Services
Vehicle Care
Food & Beverage
Total United States Cleaning & Sanitizing
United States Other Services
Pest Elimination
GCS Service
Total United States Other Services
Total United States
Europe
Asia Pacific
Latin America
Canada
Total International Cleaning & Sanitizing
Consolidated (management rates)
Consolidated (public rates)
Sales of the companys United States Cleaning & Sanitizing segment were $445 million, an increase of 4 percent compared with sales of $426 million in the third quarter of last year. United States Cleaning & Sanitizing sales were $1.293 billion for the first nine months of 2003, up 6 percent over net sales of $1.221 billion in the comparable period of last year. Sales benefited from good growth in Kay and Professional Products operations, which were partially offset by lower sales in Textile Care. The increase in sales of the companys Institutional division reflects Institutionals continued efforts to generate new accounts, the successful introduction of new products and the benefits of improved service initiatives. Kays sales increases reflect solid growth in its food retail services business and to quickservice restaurants as well as the introduction of new products and programs, which are showing good results. Textile Care sales decreased due to soft industry demand and strong competition within the industry. Sales of Professional Products operations increased due to strong gains in the healthcare market offsetting the continuing phase-out of the specialty business. Professional Products janitorial sales were also positively impacted in the third quarter and first nine months of 2003 by a long-term supply agreement that began in December 2002. The companys Food & Beverage operations reported sales
24
increases due to gains in the soft drink, meat and poultry and food markets, which were partially offset by a decrease in agri and equipment sales. Water Care Services had strong growth in the hospitality and food & beverage accounts. The increase in sales for Vehicle Care was driven by good growth in both the in-bay and conveyor markets as well as the success of new product introductions.
Sales of the companys United States Other Services segment totaled $83 million for the third quarter of 2003, an increase of 2 percent over net sales of $82 million in the third quarter of last year. United States Other Services sales were $240 million for the first nine months of 2003, an increase of 4 percent over net sales of $231 million in the comparable period of last year. Pest Elimination sales increased with double-digit sales growth in contract services and strong growth in non-contract services. GCS Service sales decreased and reflected operational issues encountered with a transition to a new centralized administration center.
Management rate sales for the companys International Cleaning & Sanitizing segment were $400 million for the third quarter of 2003, an increase of 5 percent over sales of $380 million in the comparable quarter of last year. For the first nine months of 2003, sales also increased 5 percent to $1.150 billion from $1.094 billion during the comparable period last year. Excluding the effects of acquisitions, sales in this segment increased 2 percent for the third quarter and 3 percent for the nine-month period. Sales in Europe, excluding acquisitions and divestitures, increased 2 percent for both the third quarter and first nine months of 2003, primarily due to successful new product launches being partially offset by a weak European economy. Excluding acquisitions and divestitures, sales for Asia Pacific were flat for the third quarter and increased 2 percent for the nine-month period. Northeast Asia had a strong sales increase and Southeast Asia also showed good sales growth for the quarter offset by a sales decrease in Australia. Latin America sales rose for the quarter with sales increases in most countries. Mexico, the Caribbean, Brazil and Central America all had double-digit sales increases for the quarter. Excluding acquisitions, Latin America sales increased 9 percent for the third quarter and 6 percent for the nine-month period. Sales in Canada increased due to a continued focus on obtaining new customers and selling additional solutions to existing customers.
25
Operating income for each of the companys reportable segments for the quarter and nine months ended September 30, 2003 and 2002 is as follows:
Operating income of the companys United States Cleaning & Sanitizing segment was $82 million for the third quarter of 2003, an increase of 3 percent over operating income of $80 million in the third quarter of last year. For the first nine months of 2003, operating income was $224 million, an increase of 5 percent over operating income of $214 million in the comparable period of last year. The operating income margin for the U.S. Cleaning & Sanitizing segment decreased to 18.5 percent of sales from 18.8 percent of net sales in the third quarter of last year and decreased to 17.3 percent of sales from 17.6 percent of net sales for the nine-month period. The decline in the operating income margin reflects investments in developing the sales force and higher operating costs.
Third quarter 2003 operating income of United States Other Services was $9 million, a decrease of 19 percent from the third quarter of last year. For the nine-month period, operating income was $19 million, a decrease of 24 percent from the comparable period last year. The operating income margin for United States Other Services decreased to 10.5 percent from 13.2 percent from the third quarter of last year. For the nine-month period, the operating income margin was 8.0 percent, a decrease from 10.9 percent for the same period last year. Pest Elimination had strong operating income growth while GCS results reflected an operating loss due to a decrease in sales resulting from operational issues encountered with a transition to a centralized administration center. This lost revenue adversely impacted operating income.
Operating income (at management rates) of International Cleaning & Sanitizing segment was $49 million for the third quarter of 2003 and increased 17 percent over operating income of $42 million in the third quarter of last year. For the first nine months of 2003, operating income was $113 million and increased 14 percent over operating income of $98
26
million in the comparable period of last year. Excluding acquisitions and divestitures, operating income increased 9 percent over the comparable quarter of last year and 12 percent for the nine-month period. The operating income margin increased to 12.2 percent of net sales in the third quarter of 2003 from 11.0 percent in the comparable period of last year. For the nine-month period ended September 30, 2003, the operating income margin increased to 9.8 percent of net sales from 9.0 percent in the comparable period of last year. Excluding acquisitions and divestitures, the operating income margin for International increased to 12.4 percent of net sales from 11.6 percent in the third quarter of last year and increased to 10.2 percent of net sales from 9.4 percent for the nine-month period. Good operating income growth and margin improvement in Europe and Canada during the third quarter and nine months ended September 30, 2003 contributed to this increase. Asia Pacific also showed good operating income growth and margin improvement for the first nine months of 2003. Operating income was also strong in most of the Latin America countries. International operating income margin improvement was primarily due to the introduction of new products and careful cost management.
Corporate operating expense was $1.2 million for the third quarter of 2003 as compared to $2.4 million for the comparable quarter last year. For the nine-month period, corporate operating expense was $0.8 million as compared to $33.6 million for the comparable period last year. Corporate operating expense for the third quarter and for the nine months ended September 30, 2003 includes approximately $1.7 million of expense related to a change in the amount of goodwill allocated to the Darenas business (a U.K. janitorial business). It also includes $0.5 million and $0.8 million of reductions in restructuring expense for the third quarter and nine months ended September 30, respectively. Corporate operating expense in the third quarter and first nine months of 2002 included restructuring and merger integration costs of $2.4 million and $39.4 million, respectively, which were partially offset by a curtailment gain of $5.8 million in the first quarter and first nine months of 2002 related to benefit plan changes.
Net interest expense totaled $12.1 million in the third quarter of 2003, an increase of 10 percent from net interest expense of $11.0 million in the third quarter of 2002. For the nine-month period, net interest expense was $34.5 million and $33.5 million for 2003 and 2002, respectively. The increase is primarily due to the strength of the euro against the U.S. dollar.
The provision for income taxes for the first nine months of 2003 reflected an effective income tax rate of 39.1 percent as compared to an effective income tax rate of 40.2 percent for 2002. Excluding the effects of the gain on the sale of an equity investment and the reduction of previously expensed restructuring charges, the effective income tax rate was 38.8 percent for the first nine months of 2003. Excluding the effects of restructuring and the curtailment gain, the effective income tax rate was 39.9 percent for the first nine months of 2002. The reduction in the 2003 effective tax rate is primarily due to a lower overall international rate and improved international mix.
27
Total assets were $3.065 billion at September 30, 2003, an increase of 7 percent over total assets at year-end 2002. This increase was largely due to the effects of currency due to changes in exchange rates as well as businesses acquired since year-end.
Total debt was $649 million at September 30, 2003, down slightly from total debt of $700 million at year-end 2002. The ratio of total debt to capitalization was 35 percent at September 30, 2003, compared to 39 percent at December 31, 2002 due to a decrease in total debt outstanding and an increase in shareholders equity since year end 2002. The company is in compliance with all of its debt covenants.
In June 2003, the company established a $200 million European commercial paper program to provide a source of funding for European and other international acquisitions and working capital requirements. The program is in addition to the companys $450 million U.S. and $200 million Australian dollar programs. All three programs are rated A-1 by Standard & Poors and P-1 by Moodys and are supported by the Companys $275 million multi-year committed credit facility (terminating December 2005) and a $175 million 364-day committed credit facility (terminating October 2003). The $175 million 364-day committed credit facility was renewed subsequent to September 30, 2003 through October 2004.
Cash provided by operating activities totaled $399 million and $368 million, for the first nine months of 2003 and 2002, respectively. Operating cash flows for 2003 primarily reflect higher net income than in 2002 offset by payments on restructuring liabilities which were expensed in 2002.
The company currently expects to fund all of the requirements which are reasonably foreseeable for the remainder of 2003, including new program investments, scheduled debt repayments, dividend payments, possible acquisitions, share repurchases and pension contributions from operating activities, cash reserves and short-term borrowings.
28
Period
(a) Totalnumber ofsharespurchased(1)
(b)Averagepricepaid pershare
(c)Identity ofbroker-dealerused to effectpurchases
(d)Number ofsharespurchased aspart ofpubliclyannouncedplans orprograms(2)
(e)Maximum numberof shares thatmay yet bepurchased underthe plans orprograms(3)
Month #1(July 1-31, 2003)
834,900
24.8838
Banc of America Securities, LLC
3,256,400
Month #2(August 1-31, 2003)
1,149,300
25.4655
2,107,100
Month #3(September 1-30, 2003)
696,400
26.0126
1,410,700
2,680,600
25.4265
(1) Excludes an additional 46,643 shares reacquired from employees and/or non-employee directors to satisfy minimum statutory tax obligations and/or shares tendered to the company to exercise a stock option, all under the companys incentive stock programs. The aggregate average price paid per share for such 46,643 reacquired shares, booked at the fair market value of the companys common stock on the date of such transactions, was $25.22.
(2) On December 7, 2000, the company announced that its Board of Directors authorized the company to repurchase up to 10,000,000 shares of common stock (adjusted for the companys stock split paid June 6, 2003) in open market or privately negotiated transactions. As part of such repurchase authorization, the company announced on March 18, 2003 that it may also repurchase shares under Rule 10b5-1 of the Securities Exchange Act of 1934, during times when it ordinarily would not be in the market because of self-imposed trading blackout periods.
(3) Subsequent to the quarter ended September 30, 2003, the company announced on October 17, 2003 that its Board of Directors authorized the repurchase of up to 10,000,000 additional shares of common stock, including shares to be repurchased under its existing Rule 10b5-1 program. As of October 31, 2003, the maximum number of shares available for repurchase under existing authority was 10,815,400. The company intends to repurchase all shares under such existing authorizations, for which no expiration date has been established, subject to market conditions.
29
In September 2003 (subsequent to the companys International operations quarter-end), the company sold the consumer dermatology business of its Adams Healthcare subsidiary to Ferndale Pharmaceuticals Ltd., in Leeds, United Kingdom at a nominal gain. The annualized sales of the dermatology business that was sold were approximately $2.5 million. These operations were part of the companys International Cleaning & Sanitizing segment.
Item 3. Quantitative and Qualitative Disclosures about Market Risk.
The company uses primarily interest rate swaps and foreign currency forward contracts and foreign currency debt to manage risks generally associated with foreign exchange rate and interest rate volatility and net investments in its foreign operations. To the extent applicable, all derivative instruments are designated and effective as hedges, in accordance with accounting principles generally accepted in the United States of America. The company does not hold derivative financial instruments of a speculative nature. For a more detailed discussion of derivative instruments, refer to the notes to consolidated financial statements in the companys Annual Report on Form 10-K for the year ended December 31, 2002.
a. As of the end of the period covered by this report, the company carried out an evaluation, under the supervision and with the participation of the companys management, including the Chairman of the Board and Chief Executive Officer and the Senior Vice President and Chief Financial Officer, of the effectiveness of the design and operation of the companys disclosure controls and procedures. Based upon that evaluation, the companys Chairman of the Board and Chief Executive Officer and the Senior Vice President and Chief Financial Officer concluded that the companys disclosure controls and procedures are effective, among other things, in timely alerting them to material information relating to the company (including its consolidated subsidiaries) required to be included in the companys reports filed under the Securities Exchange Act of 1934, as amended.
b. There were no changes in the companys internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, the companys internal control over financial reporting that occurred during the fiscal quarter covered by this quarterly report.
30
The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements. In this report on Form 10-Q, management discusses expectations regarding future performance of the company which include anticipated restructuring savings, investments in the business, favorable liquidity, and similar business and financial matters. Without limiting the foregoing, words or phrases such as will likely result, are expected to, will continue, is anticipated, we believe, estimate, project (including the negative or variations thereof) or similar terminology, generally identify forward-looking statements. Additionally, the company may refer to this section of the Form 10-Q to identify risk factors related to other forward looking statements made in oral presentations including telephone conferences and/or webcasts open to the public.
Forward-looking statements represent challenging goals for the company. As such, they are based on certain assumptions and estimates and are subject to certain risks and uncertainties. The company cautions that undue reliance should not be placed on such forward-looking statements, which speak only as of the date made. In order to comply with the terms of the safe harbor, the company hereby identifies important factors, which could affect the companys financial performance and could cause the companys actual results for future periods to differ materially from the anticipated results or other expectations expressed in the forward-looking statements. These factors should be considered, together with any similar risk factors or other cautionary language, which may be made in the section of this report containing the forward-looking statement.
Risks and uncertainties that may affect operating results and business performance include: the vitality of the foodservice, hospitality and travel industries; restraints on pricing flexibility due to competitive factors and customer and vendor consolidations; changes in oil or raw material prices or unavailability of adequate and reasonably priced raw materials; the occurrence of capacity constraints or the loss of a key supplier; the effect of future acquisitions or divestitures or other corporate transactions; the companys ability to achieve plans for past acquisitions; the costs and effects of complying with (i) laws and regulations relating to the environment and to the manufacture, storage, distribution, efficacy and labeling of the companys products and (ii) changes in tax, fiscal, governmental and other regulatory policies; economic factors such as the worldwide economy, interest rates and currency movements, including, in particular, the companys exposure to foreign currency risk; the occurrence of (a) litigation or claims, (b) the loss or insolvency of a major customer or distributor, (c) war, (d) natural or manmade disasters (including material acts of terrorism or other hostilities which impact the companys markets) and, (e) severe weather conditions or public health epidemics affecting the foodservice, hospitality, and travel industries; loss of, or changes in, executive management; the companys ability to continue product introductions and technological innovations; and other uncertainties or risks reported from time-to-time in the companys reports to the Securities and Exchange Commission. In addition, the company notes that its stock price can be affected by fluctuations in quarterly earnings. There can be no assurances that companys earnings levels will meet investors expectations.
31
PART II. OTHER INFORMATION
Item 6.
Exhibits and Reports on Form 8-K.
(a)
The following documents are filed as exhibits to this report:
(15)
Letter regarding unaudited interim financial information.
(31)
Rule 15d-14(a) Certifications.
(32)
Section 1350 Certifications.
(b)
Reports on Form 8-K:
During the quarter ended September 30, 2003, the Company furnished a Current Report dated July 22, 2003 to the SEC under Items 9 and 12 of Form 8-K to disseminate earnings for the second quarter ended June 30, 2003.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Date: November 4, 2003
By:
/s/ Daniel J. Schmechel
Daniel J. Schmechel
Vice President and Controller(duly authorized Officer andChief Accounting Officer)
ExhibitNo.
Document
Method ofFiling
Filed herewith electronically
Furnished herewith electronically